Literature DB >> 33981698

Optical Coherence Tomography of Peri-Ocular Skin Cancers: An Optical Biopsy.

Sabrina Bergeron1, Bryan Arthurs2, Debra-Meghan Sanft2, Christina Mastromonaco1, Miguel N Burnier1,2.   

Abstract

INTRODUCTION: Optical coherence tomography (OCT) imaging has been used as a diagnostic tool for retinal disease for several years, and OCT apparatuses are becoming increasingly powerful. However, OCT has yet to reach its full potential in ophthalmology clinics. Alike retinal layers, it has been shown that OCT is able to generate cross-sectional images of the skin and allows visualization of skin lesions in a histopathology-like manner.
OBJECTIVE: We aim to validate OCT as an imaging modality for peri-ocular skin cancer. Through a series of cases, we highlight findings for 3 common eyelid malignancies: basal cell carcinoma, squamous cell carcinoma and sebaceous carcinoma. We propose an OCT image-based signature for basal cell carcinoma.
METHODS: This is a prospective study. Fifty-eight lesions suspicious of malignancy from 57 patients were subjected to OCT imaging prior to the surgical excision of the lesion. OCT images were analysed and scored according to previously identified OCT features. Eight representative examples are presented, highlighting the OCT patterns for each malignancy side by side to its corresponding histopathological sections.
RESULTS: Out of the 58 lesions analysed, 53 were malignant. A loss of the dermal-epidermal junction is observed in all malignant lesions. A strong link is observed between the presence of subepithelial hyporeflective nests on OCT and the diagnosis of basal cell carcinoma (present in 83% of cases). Conversely, lesions of epithelial origin such as squamous cell carcinoma are most often represented on OCT by acanthosis. Two supplementary cases, one basal cell carcinoma and one sebaceous carcinoma, are provided to illustrate how OCT imaging is a valuable tool in cases where clinical observations may be unusual.
CONCLUSIONS: We provide evidence supporting the use of OCT for the evaluation of peri-ocular cancers. OCT enables visualization of the skin layers in vivo, before biopsy. Our results show that certain OCT features can contribute to include or exclude a diagnosis of basal cell carcinoma. By integrating this non-invasive imaging methodology into the routine assessment of peri-ocular skin lesions, especially in health care centres where access to specialists is limited, OCT imaging can increase clinical precision, reduce delays in patient referral and enhance patient care.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Adnexal tumours; Basal cell carcinoma; Dermatology; Eyelids; Histopathology; Non-melanoma skin cancer; Ocular pathology; Oculoplastics; Optical coherence tomography

Year:  2020        PMID: 33981698      PMCID: PMC8077514          DOI: 10.1159/000511188

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  29 in total

1.  Sensitivity and specificity of the diagnosis of periocular lesions by oculoplastic surgeons.

Authors:  T R Hillson; J T Harvey; J J Hurwitz; E Liu; J H Oestreicher; R C Pashby
Journal:  Can J Ophthalmol       Date:  1998-12       Impact factor: 1.882

Review 2.  High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology.

Authors:  Afshan A Nanji; Fouad E Sayyad; Anat Galor; Sander Dubovy; Carol L Karp
Journal:  Ocul Surf       Date:  2015-04-06       Impact factor: 5.033

3.  Optimizing optical coherence tomography and histopathology correlation in retinal imaging.

Authors:  Carlos A Moreira-Neto; Sabrina Bergeron; Jacqueline Coblentz; Pablo Zoroquiain; Shawn Maloney; Christina Mastromonaco; Evangelina Esposito; André Romano; Rubens Belfort Neto; Carlos A Moreira; Julia V Burnier; Miguel Burnier
Journal:  Can J Ophthalmol       Date:  2018-08-27       Impact factor: 1.882

Review 4.  Techniques and Applications in Skin OCT Analysis.

Authors:  Ai Ping Yow; Ruchir Srivastava; Jun Cheng; Annan Li; Jiang Liu; Leopold Schmetterer; Hong Liang Tey; Damon W K Wong
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Optical coherence tomography-based optimization of mohs micrographic surgery of Basal cell carcinoma: a pilot study.

Authors:  Katie Xiaoyi Wang; Adam Meekings; Joachim W Fluhr; Gordon McKenzie; David A Lee; Juliya Fisher; Orit Markowitz; Daniel M Siegel
Journal:  Dermatol Surg       Date:  2013-01-07       Impact factor: 3.398

6.  Accuracy of optical coherence tomography for the diagnosis of superficial basal cell carcinoma: a prospective, consecutive, cohort study of 168 cases.

Authors:  H M Cheng; S Lo; R Scolyer; A Meekings; G Carlos; P Guitera
Journal:  Br J Dermatol       Date:  2016-09-24       Impact factor: 9.302

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Optical coherence tomography for diagnosing skin cancer in adults.

Authors:  Lavinia Ferrante di Ruffano; Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Susan E Bayliss; Clare Davenport; Yemisi Takwoingi; Kathie Godfrey; Colette O'Sullivan; Rubeta N Matin; Hamid Tehrani; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

9.  Correlation between SD-OCT, immunocytochemistry and functional findings in an animal model of retinal degeneration.

Authors:  Nicolás Cuenca; Laura Fernández-Sánchez; Yves Sauvé; Francisco J Segura; Gema Martínez-Navarrete; José Manuel Tamarit; Lorena Fuentes-Broto; Ana Sanchez-Cano; Isabel Pinilla
Journal:  Front Neuroanat       Date:  2014-12-22       Impact factor: 3.856

10.  Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.

Authors:  Ann Q Tran; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.